Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

Frontiers in Immunology

Immunology

Kenan Cen¹  Ying Dai¹  Yifeng Mai¹  Kai Hong²  Yangyang Guo²  Qiaoqiao Chen³ 

[1] Department of Geriatrics Medicine, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China;Department of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, Zhejiang, China;Department of Thyroid and Breast Surgery, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang, China;Reproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China;Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;

关键词: thyroid cancer;    cellular senescence;    tumor microenvironment;    signature;    immunotherapy;    prognosis;   

DOI  :  10.3389/fimmu.2023.1229541

 received in 2023-05-26, accepted in 2023-05-30,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Guo, Cen, Chen, Dai, Mai and Hong